For most solid tumors, minimally invasive approaches such as ablation and interventional therapies may be considered following evaluation. Common indications include primary and metastatic liver cancer, lung cancer, kidney cancer, pancreatic cancer, thyroid nodules and thyroid cancer, prostate cancer, uterine fibroids, breast fibroadenomas, and bone and soft tissue tumors.
Minimally invasive treatment may also be considered as part of a comprehensive treatment strategy for patients with multiple metastases, older patients, and those in poorer overall health. Whether a particular treatment is appropriate must be determined based on CT, MRI, PET-CT, pathology reports, and other relevant medical records, followed by a preliminary assessment by our specialist team.

Minimally invasive treatment and surgery are not competing approaches; rather, they play complementary roles in comprehensive cancer care. Surgery primarily focuses on the curative resection of early-stage tumors, while minimally invasive treatment aims to achieve precise local tumor control with minimal invasiveness.
For patients with intermediate- or advanced-stage cancer that is considered unresectable, or for those who prefer not to undergo surgery, a comprehensive approach combining minimally invasive interventional therapy or ablation with chemotherapy, radiation therapy, targeted therapy, or immunotherapy may help relieve symptoms, preserve organ function, and improve quality of life. In clinical practice, some patients whose tumors were initially considered unresectable have achieved long-term disease control and survival following combined minimally invasive treatment.

For safety and appropriate clinical monitoring, most minimally invasive procedures are performed during a hospital stay. A typical hospital stay for a single treatment session is approximately 3-7 days. Compared with conventional open chest or abdominal surgery, hospitalization and recovery times are generally shorter.
For international patients, treatment schedules are also coordinated based on the treatment cycle, the patient's recovery, and visa validity. Some treatments, including certain interventional procedures, need to be performed in stages. In these cases, doctors plan the treatment intervals accordingly to minimize the need for repeated travel to and from China whenever possible.

① Submit Medical Records: We recommend providing recent imaging studies, pathology reports, laboratory test results, and records of previous treatments. Once the records are received, our specialist team will conduct a preliminary assessment of the patient’s condition, helping the patient understand potential treatment options before traveling to China and plan the trip accordingly.
② Travel Arrangements: If needed, our hospital can provide relevant medical documentation to assist with the visa application process. Patients who send their flight or train itinerary to and from Guangzhou in advance can arrange complimentary transportation to and from the airport or high-speed railway station.
③ Language & Accommodation: Our hospital provides interpretation support in multiple languages, including Chinese, English, Russian, and Mongolian. Our team can assist with admission procedures, payments and medication collection, communication with medical staff, document translation, and other matters during the patient’s stay. During treatment intervals when hospitalization is not required, patients may stay at nearby hotels, and our international medical team can provide accommodation recommendations and transportation guidance.
④ Commercial Health Insurance: Patients with international private health insurance are advised to confirm reimbursement requirements with their insurance provider in advance. Based on the care actually provided, our hospital can assist by providing relevant documentation, including medical records and itemized statements of charges.